Ramos Rheumatology Ransomware Attack by DragonForce (May 2026)

Claim Summary

The DragonForce ransomware group has allegedly claimed responsibility for a cyberattack against Ramos Rheumatology, a healthcare provider based in Avoca, Pennsylvania. According to a post on the group’s leak site dated May 27, 2026, the threat actor claims to have exfiltrated sensitive data from the practice. Ramos Rheumatology specializes in the diagnosis and treatment of autoimmune diseases, including lupus, rheumatoid arthritis, and fibromyalgia, and emphasizes personalized, compassionate care. The group has not disclosed the volume of data allegedly stolen, nor has it provided any samples or proof of compromise at this time. Yazoul Security has not independently verified these claims.

Threat Actor Profile

DragonForce is a relatively opaque ransomware group with limited public attribution. While the group’s total number of known victims remains unknown, it has demonstrated operational capability through the use of several well-known post-exploitation and reconnaissance tools. According to available intelligence, DragonForce has been observed deploying:

• Mimikatz – for credential dumping and lateral movement
• Advanced IP Scanner – for network discovery
• PingCastle – for Active Directory security auditing and privilege escalation
• SoftPerfect NetScan – for network scanning and asset inventory

These tools suggest a methodical approach to network compromise, often indicative of hands-on-keyboard activity rather than automated ransomware deployment. However, the lack of public research or YARA rules specific to DragonForce makes detection and attribution challenging. Organizations should monitor for the use of these tools in their environments as potential indicators of DragonForce activity.

Alleged Data Exposure

The DragonForce leak site post claims that Ramos Rheumatology’s data has been compromised, but no specific file types, patient records, or financial documents have been listed. The group’s description of the victim mirrors publicly available marketing material from the practice’s website, which may indicate a low-effort or opportunistic targeting. Without proof of data exfiltration, the credibility of this claim remains low. Ransomware groups frequently exaggerate or fabricate data theft to pressure victims into paying ransoms.

Potential Impact

If the claim is verified, the impact on Ramos Rheumatology could be significant. As a healthcare provider, the practice handles protected health information (PHI) including patient names, diagnoses, treatment plans, and insurance details. A breach of this nature could lead to:

• Regulatory penalties under HIPAA for failure to safeguard PHI
• Loss of patient trust and reputational damage
• Potential identity theft or medical fraud for affected individuals
• Operational disruption if systems were encrypted or taken offline

The practice’s small size and focus on personalized care may make it particularly vulnerable to reputational harm and patient churn following a public breach announcement.

What to Watch For

• Leak site updates – DragonForce may post additional data or proof of compromise in the coming days
• Patient communications – Ramos Rheumatology may issue breach notifications or public statements
• Dark web chatter – The stolen data, if real, may be sold or shared on other forums
• Indicators of compromise – Monitor for DragonForce-associated tools (Mimikatz, Advanced IP Scanner, PingCastle, SoftPerfect NetScan) in network logs

Yazoul Security will continue to monitor DragonForce’s activities. For further guidance on ransomware defense, visit our advisory page at /advisory/ransomware-preparedness/.

Disclaimer

This report is based on unverified claims made by the DragonForce ransomware group on their leak site. Yazoul Security has not independently confirmed the breach, the extent of data exfiltration, or the identity of the victim. Ransomware groups frequently exaggerate or falsify claims to coerce ransom payments. Readers should treat this information as preliminary and seek official confirmation from Ramos Rheumatology or relevant authorities before taking action.